$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Inducible resistance to Fas-mediated apoptosis in B cells 원문보기

Cell research, v.10 no.4, 2000년, pp.245 - 266  

ROTHSTEIN, Thomas L

Abstract AI-Helper 아이콘AI-Helper

Apoptosis produced in B cells through Fas (APO-1, CD95) triggering is regulated by signals derived from other surface receptors: CD40 engagement produces upregulation of Fas expression and marked susceptibility to Fas-induced cell death, whereas antigen receptor engagement, or IL-4R engagement, inhi...

참고문헌 (155)

  1. J Exp Med S Yonehara 169 1747 1989 10.1084/jem.169.5.1747 Yonehara S, Ishii A, Yonehara M . A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 1989; 169:1747-56. 

  2. Science BC Trauth 245 301 1989 10.1126/science.2787530 Trauth BC, Klas C, Peters AM, et al. Monoclonal antibody- mediated tumor regression by induction of apoptosis. Science 1989; 245:301-5. 

  3. Cell S Nagata 88 355 1997 10.1016/S0092-8674(00)81874-7 Nagata S . Apoptosis by death factor. Cell 1997; 88:355-65. 

  4. Science AM Chinnaiyan 274 990 1996 10.1126/science.274.5289.990 Chinnaiyan AM, O'Rourke K, Yu GL, et al. Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95. Science 1996;,B. 274:990-2. 

  5. Immunity PM Chaudhary 7 821 1997 10.1016/S1074-7613(00)80400-8 Chaudhary PM, Eby M, Jasmin A, Bookwalter A, Murray J, Hood L . Death receptor 5, a new member of the TNFR family, and DR4 induce FADD- dependent apoptosis and activate the NF- κ B pathway. Immunity 1997; 7:821-30. 

  6. Immunity P Schneider 7 831 1997 10.1016/S1074-7613(00)80401-X Schneider P, Thome M, Burns K, et al. TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-κB. Immunity 1997; 7:831-6. 

  7. Science WC Yeh 279 1954 1998 10.1126/science.279.5358.1954 Yeh WC, Pompa JL, McCurrach ME, et al. FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. Science 1998; 279:1954-8. 

  8. J Immunol T Suda 154 3806 1995 10.4049/jimmunol.154.8.3806 Suda T, Okazaki T, Naito Y, et al. Expression of the Fas ligand in cells of T cell lineage. J Immunol 1995; 154:3806-13. 

  9. Transplantation MJ Smyth 62 1529 1996 10.1097/00007890-199611270-00030 Smyth MJ, Sutton VR, Kershaw MH, Trapani JA . Xenospecific cytotoxic T lymphocytes use perforin- and Fas-mediated lytic pathways. Transplantation 1996; 62:1529-32. 

  10. Immunol Rev S Hahn 146 57 1995 10.1111/j.1600-065X.1995.tb00684.x Hahn S, Gehri R, Erb P . Mechanism and biological significance of CD4-mediated cytotoxicity. Immunol Rev 1995; 146:57-79. 

  11. J Exp Med H Arase 181 1235 1995 10.1084/jem.181.3.1235 Arase H, Arase N, Saito T . Fas-mediated cytotoxicity by freshly isolated natural killer cells. J Exp Med 1995; 181:1235-8. 

  12. Cell Immunol AH Montel 166 236 1995 10.1006/cimm.1995.9974 Montel AH, Bochan MR, Hobbs JA, Lynch DH, Brahmi Z . Fas involvement in cytotoxicity mediated by human NK cells. Cell Immunol 1995; 166:236-46. 

  13. J Immunol Y Oshimi 157 2909 1996 10.4049/jimmunol.157.7.2909 Oshimi Y, Oda S, Honda Y, Nagata S, Miyazaki S . Involvement of Fas ligand and Fas-mediated pathway in the cytotoxicity of human natural killer cells. J Immunol 1996; 157:2909-15. 

  14. Annu Rev Immunol PL Cohen 9 243 1991 10.1146/annurev.iy.09.040191.001331 Cohen PL, Eisenberg RA . Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu Rev Immunol 1991; 9:243-69. 

  15. Nature R Watanabe-Fukunaga 356 314 1992 10.1038/356314a0 Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S . Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992; 356:314-7. 

  16. Cell T Takahashi 76 969 1994 10.1016/0092-8674(94)90375-1 Takahashi T, Tanaka M, Brannan CI, et al. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 1994; 76:969-76. 

  17. Cell GH Fisher 81 935 1995 10.1016/0092-8674(95)90013-6 Fisher GH, Rosenberg FJ, Straus SE, et al. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 1995; 81:935-46. 

  18. Science F Rieux-Laucat 268 1347 1995 10.1126/science.7539157 Rieux-Laucat F, Le Deist F, Hivroz C, et al. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 1995; 268:1347-9. 

  19. N Engl J Med J Drappa 335 1643 1996 10.1056/NEJM199611283352204 Drappa J, Vaishnaw AK, Sullivan KE, Chu JL, Elkon KB . Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity [see comments]. N Engl J Med 1996; 335:1643-9. 

  20. J Clin Invest J Wu 98 1107 1996 10.1172/JCI118892 Wu J, Wilson J, He J, Xiang L, Schur PH, Mountz JD . Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease. J Clin Invest 1996; 98:1107-13. 

  21. Lancet F Le Deist 348 719 1996 10.1016/S0140-6736(96)02293-3 Le Deist F, Emile JF, Rieux- Laucat F, et al. Clinical, immunological, and pathological consequences of Fas-deficient conditions. Lancet 1996; 348:719-23. 

  22. Cell J Wang 98 47 1999 10.1016/S0092-8674(00)80605-4 Wang J, Zheng L, Lobito A, et al. Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II. Cell 1999; 98:47-58. 

  23. Immunol Today S Nagata 16 39 1995 10.1016/0167-5699(95)80069-7 Nagata S, Suda T . Fas and Fas ligand: lpr and gld mutations. Immunol Today 1995; 16:39-43. 

  24. Proc Natl Acad Sci U S A M Adachi 93 2131 1996 10.1073/pnas.93.5.2131 Adachi M, Suematsu S, Suda T, et al. Enhanced and accelerated lymphoproliferation in Fas-null mice. Proc Natl Acad Sci U S A 1996; 93:2131-6. 

  25. J Immunol DL Perkins 139 1406 1987 10.4049/jimmunol.139.5.1406 Perkins DL, Michaelson J, Glaser RM, Marshak-Rothstein A . Selective elimination of non- lpr lymphoid cells in mice undergoing lpr-mediated graft-vs-host disease. J Immunol 1987; 139:1406-13. 

  26. J Immunol D Nemazee 147 2536 1991 10.4049/jimmunol.147.8.2536 Nemazee D, Guiet C, Buerki K, Marshak-Rothstein A . B lymphocytes from the autoimmune-prone mouse strain MLR/ lpr manifest an intrinsic defect in tetraparental MRL/ lpr in equilibrium DBA/2 chimeras. J Immunol 1991; 147:2536-9. 

  27. J Immunol ES Sobel 160 1497 1998 10.4049/jimmunol.160.3.1497 Sobel ES, Kakkaaiah VN, Schiffenbauer J, Reap EA, Cohen PL, Eisenberg RA . Novel immunoregulatory B cell pathways revealed by lpr-+ mixed chimeras. J Immunol 1998; 160:1497-503. 

  28. J Immunol H Fukuyama 160 3805 1998 10.4049/jimmunol.160.8.3805 Fukuyama H, Adachi M, Suematsu S, et al. Transgenic expression of Fas in T cells blocks lymphoproliferation but not autoimmune disease in MRL- lpr mice. J Immunol 1998; 160:3805-11. 

  29. J Immunol T Stalder 152 1127 1994 10.4049/jimmunol.152.3.1127 Stalder T, Hahn S, Erb P . Fas antigen is the major target molecule for CD4+ T cell-mediated cytotoxicity. J Immunol 1994; 152:1127-33. 

  30. Proc Natl Acad Sci USA ST Ju 91 4185 1994 10.1073/pnas.91.10.4185 Ju ST, Cui H, Panka DJ, Ettinger R, Marshak-Rothstein A . Participation of target Fas protein in apoptosis pathway induced by CD4+ Th1 and CD8+ cytotoxic T cells. Proc Natl Acad Sci USA 1994; 91:4185-9. 

  31. J Immunol PT Daniel 152 5624 1994 10.4049/jimmunol.152.12.5624 Daniel PT, Krammer PH . Activation induces sensitivity toward APO-1 (CD95)-mediated apoptosis in human B cells. J Immunol 1994; 152:5624-32. 

  32. Int Immunol D Watanabe 7 1949 1995 10.1093/intimm/7.12.1949 Watanabe D, Suda T, Nagata S . Expression of Fas in B cells of the mouse germinal center and Fas-dependent killing of activated B cells. Int Immunol 1995; 7:1949-56. 

  33. Eur J Immunol KB Onel 25 2940 1995 10.1002/eji.1830251034 Onel KB, Tucek-Szabo CL, Ashany D, Lacy E, Nikolic-Zugic J, Elkon KB . Expression and function of the murine CD95/FasR/APO-1 receptor in relation to B cell ontogeny. Eur J Immunol 1995; 25:2940-7. 

  34. Nature TL Rothstein 374 163 1995 10.1038/374163a0 Rothstein TL, Wang JK, Panka DJ, et al. Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells. Nature 1995; 374:163-5. 

  35. J Immunol LC Foote 157 1878 1996 10.4049/jimmunol.157.5.1878 Foote LC, Schneider TJ, Fischer GM, et al. Intracellular signaling for inducible antigen receptor-mediated Fas resistance in B cells. J Immunol 1996; 157:1878-85. 

  36. J Exp Med LC Foote 187 847 1998 10.1084/jem.187.6.847 Foote LC, Marshak-Rothstein A, Rothstein TL . Tolerant B lymphocytes acquire resistance to Fas-mediated apoptosis after treatment with interleukin 4 but not after treatment with specific antigen unless a surface immunoglobulin threshold is exceeded. J Exp Med 1998; 187:847-53. 

  37. J Immunol LC Foote 157 2749 1996 10.4049/jimmunol.157.7.2749 Foote LC, Howard RG, Marshak-Rothstein A, Rothstein TL . IL-4 induces Fas resistance in B cells. J Immunol 1996; 157:2749-53. 

  38. J Exp Med EJ Schattner 182 1557 1995 10.1084/jem.182.5.1557 Schattner EJ, Elkon KB, Yoo DH, et al. CD40 ligation induces Apo- 1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway. J Exp Med 1995; 182:1557-65. 

  39. J Exp Med P Garrone 182 1265 1995 10.1084/jem.182.5.1265 Garrone P, Neidhardt EM, Garcia E, Galibert L, van Kooten C, Banchereau J . Fas ligation induces apoptosis of CD40-activated human B lymphocytes. J Exp Med 1995; 182:1265-73. 

  40. J Exp Med C Lagresle 183 1377 1996 10.1084/jem.183.4.1377 Lagresle C, Mondiere P, Bella C, Krammer PH, Defrance T . Concurrent engagement of CD40 and the antigen receptor protects naive and memory human B cells from APO-1/Fas-mediated apoptosis. J Exp Med 1996; 183:1377-88. 

  41. Cell JC Rathmell 87 319 1996 10.1016/S0092-8674(00)81349-5 Rathmell JC, Townsend SE, Xu JC, Flavell RA, Goodnow CC . Expansion or elimination of B cells in vivo: dual roles for CD40- and Fas (CD95)-ligands modulated by the B cell antigen receptor. Cell 1996; 87:319-29. 

  42. Wurster AL, Rothstein TL, Grusby MJ . IL-4 protects primary B cells from apoptosis through Stat6-dependent upregulation of Bcl-xL. Submitted. 

  43. J Immunol JG Karras 157 39 1996 10.4049/jimmunol.157.1.39 Karras JG, Wang Z, Coniglio SJ, Frank DA, Rothstein TL . Antigen-receptor engagement in B cells induces nuclear expression of STAT5 and STAT6 proteins that bind and transactivate an IFN-γ activation site. J Immunol 1996; 157:39-47. 

  44. Eur J Immunol GG Klaus 16 92 1986 10.1002/eji.1830160118 Klaus GG, O'Garra A, Bijsterbosch MK, Holman M . Activation and proliferation signals in mouse B cells. VIII. Induction of DNA synthesis in B cells by a combination of calcium ionophores and phorbol myristate acetate. Eur J Immunol 1986; 16:92-7. 

  45. Cell Immunol TL Rothstein 102 364 1986 10.1016/0008-8749(86)90430-2 Rothstein TL, Baeker TR, Miller RA, Kolber DL . Stimulation of murine B cells by the combination of calcium ionophore plus phorbol ester. Cell Immunol 1986; 102:364-73. 

  46. J Exp Med DG Sieckmann 147 814 1978 10.1084/jem.147.3.814 Sieckmann DG, Asofsky R, Mosier DE, Zitron IM, Paul . Activation of mouse lymphocytes by anti-immunoglobulin. I. Parameters of the proliferative response. J Exp Med 1978; 147:814-29. 

  47. Science DJ Rawlings 261 358 1993 10.1126/science.8332901 Rawlings DJ, Saffran DC, Tsukada S, et al. Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice. Science 1993; 261:358-61. 

  48. Immunity WN Khan 3 283 1995 10.1016/1074-7613(95)90114-0 Khan WN, Alt FW, Gerstein RM, et al. Defective B cell development and function in Btk-deficient mice. Immunity 1995; 3:283-99. 

  49. Negm RS, Schneider TJ, Colarusso TP, Woodland RT, Rothstein TL . Btk does not regulate susceptibility to Fas-mediated apoptosis nor inducible Fas-resistance in murine B cells. In preparation 2000; . 

  50. J Biol Chem A Vassilev 274 1646 1999 10.1074/jbc.274.3.1646 Vassilev A, Ozer Z, Navara C, Mahajan S, Uckun FM . Bruton' s tyrosine kinase as an inhibitor of the Fas/CD95 death-inducing signaling complex. J Biol Chem 1999; 274:1646-56. 

  51. J Exp Med TJ Schneider 189 949 1999 10.1084/jem.189.6.949 Schneider TJ, Fischer GM, Donohoe TJ, Colarusso TP, Rothstein TL . A novel gene coding for a Fas apoptosis inhibitory molecule (FAIM) isolated from inducibly Fas-resistant B lymphocytes. J Exp Med 1999; 189:949-56. 

  52. J Immunol IM Catlett 163 2378 1999 10.4049/jimmunol.163.5.2378 Catlett IM, Bishop GA . Cutting edge: a novel mechanism for rescue of B cells from CD95/Fas-mediated apoptosis. J Immunol 1999; 163:2378-81. 

  53. J Immunol JL Liu 146 1685 1991 10.4049/jimmunol.146.5.1685 Liu JL, Chiles TC, Sen RJ, Rothstein TL . Inducible nuclear expression of NF-κB in primary B cells stimulated through the surface Ig receptor. J Immunol 1991; 146:1685-91. 

  54. Eur J Immunol JW Rooney 21 2993 1991 10.1002/eji.1830211214 Rooney JW, Dubois PM, Sibley CH . Cross-linking of surface IgM activates NF-κB in B lymphocyte. Eur J Immunol 1991; 21:2993-8. 

  55. Immunol Res S Ghosh 19 183 1999 10.1007/BF02786486 Ghosh S . Regulation of inducible gene expression by the transcription factor NF- κ B. Immunol Res 1999; 19:183-9. 

  56. Blood I Jeremias 91 4624 1998 10.1182/blood.V91.12.4624 Jeremias I, Kupatt C, Baumann B, Herr I, Wirth T, Debatin KM . Inhibition of nuclear factor κB activation attenuates apoptosis resistance in lymphoid cells. Blood 1998; 91:4624-31. 

  57. Eur J Immunol E Dudley 29 878 1999 10.1002/(SICI)1521-4141(199903)29:03<878::AID-IMMU878>3.0.CO;2-9 Dudley E, Hornung F, Zheng L, Scherer D, Ballard D, Lenardo M . NF-κB regulates Fas/APO-1/CD95- and TCR-mediated apoptosis of T lymphocytes. Eur J Immunol 1999; 29:878-86. 

  58. Genes Dev WX Zong 13 382 1999 10.1101/gad.13.4.382 Zong WX, Edelstein LC, Chen C, Bash J, Gelinas C . The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NFκ-B that blocks TNF α-induced apoptosis. Genes Dev 1999; 13:382-7. 

  59. Genes Dev RJ Grumont 13 400 1999 10.1101/gad.13.4.400 Grumont RJ, Rourke IJ, Gerondakis S . Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis. Genes Dev 1999; 13:400-11. 

  60. Proc Natl Acad Sci USA HH Lee 96 9136 1999 10.1073/pnas.96.16.9136 Lee HH, Dadgostar H, Cheng Q, Shu J, Cheng G . NF-κB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes. Proc Natl Acad Sci USA 1999; 96:9136-41. 

  61. Mol Cell Biol CY Wang 19 5923 1999 10.1128/MCB.19.9.5923 Wang CY, Guttridge DC, Mayo MW, Baldwin AS, Jr . NF-κB induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis. Mol Cell Biol 1999; 19:5923-9. 

  62. Science G Fenteany 268 726 1995 10.1126/science.7732382 Fenteany G, Standaert RF, Lane WS, Choi S, Corey EJ, Schreiber SL . Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science 1995; 268:726-31. 

  63. Eur J Immunol K Matsui 27 2269 1997 10.1002/eji.1830270922 Matsui K, Omura S, Cui H, Schauer SL, Sonenshein GE, Ju ST . Proteasome regulation of Fas ligand cytotoxicity. Eur J Immunol 1997; 27:2269-78. 

  64. J Exp Med R Schreck 175 1181 1992 10.1084/jem.175.5.1181 Schreck R, Meier B, Mannel DN, Droge W, Baeuerle PA . Dithiocarbamates as potent inhibitors of nuclear factor κ B activation in intact cells. J Exp Med 1992; 175:1181-94. 

  65. J Exp Med UD Bajpai 191 1735 2000 10.1084/jem.191.10.1735 Bajpai UD, Zhang K, Teutsch M, Sen R, Wortis HH . Bruton's tyrosine kinase links the B cell receptor to nuclear factor κB activation. J Exp Med 2000; 191:1735-44. 

  66. J Exp Med JB Petro 191 1745 2000 10.1084/jem.191.10.1745 Petro JB, Rahman SM, Ballard DW, Khan WN . Bruton's tyrosine kinase is required for activation of I κ B kinase and nuclear factor κ B in response to B cell receptor engagement. J Exp Med 2000; 191:1745-54. 

  67. Blood E Yang 88 386 1996 10.1182/blood.V88.2.386.bloodjournal882386 Yang E, Korsmeyer SJ . Molecular thanatopsis: a discourse on the BCL2 family and cell death. Blood 1996; 88:386-401. 

  68. J Immunol TJ Schneider 159 4834 1997 10.4049/jimmunol.159.10.4834 Schneider TJ, Grillot D, Foote LC, Nunez GE, Rothstein TL . Bcl-x protects primary B cells against Fas-mediated apoptosis. J Immunol 1997; 159:4834-9. 

  69. Cell Immunol X Zhang 173 149 1996 10.1006/cimm.1996.0260 Zhang X, Li L, Choe J, et al. Up-regulation of Bcl-xL expression protects CD40-activated human B cells from Fas-mediated apoptosis. Cell Immunol 1996; 173:149-54. 

  70. Proc Natl Acad Sci USA DC Huang 96 14871 1999 10.1073/pnas.96.26.14871 Huang DC, Hahne M, Schroeter M, et al. Activation of Fas by FasL induces apoptosis by a mechanism that cannot be blocked by Bcl-2 or Bcl-x(L). Proc Natl Acad Sci USA 1999; 96:14871-6. 

  71. J Exp Med N Zamzami 182 367 1995 10.1084/jem.182.2.367 Zamzami N, Marchetti P, Castedo M, et al. Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J Exp Med 1995; 182:367-77. 

  72. Cancer Res D Decaudin 57 62 1997 Decaudin D, Geley S, Hirsch T, et al. Bcl-2 and Bcl-XL antagonize the mitochondrial dysfunction preceding nuclear apoptosis induced by chemotherapeutic agents. Cancer Res 1997; 57:62-7. 

  73. Hepatology AS Arora 25 958 1997 10.1002/hep.510250428 Arora AS, Jones BJ, Patel TC, Bronk SF, Gores GJ . Ceramide induces hepatocyte cell death through disruption of mitochondrial function in the rat. Hepatology 1997; 25:958-63. 

  74. J Biol Chem TI Gudz 272 24154 1997 10.1074/jbc.272.39.24154 Gudz TI, Tserng KY, Hoppel CL . Direct inhibition of mitochondrial respiratory chain complex III by cell-permeable ceramide. J Biol Chem 1997; 272:24154-8. 

  75. J Biol Chem C Scaffidi 274 22532 1999 10.1074/jbc.274.32.22532 Scaffidi C, Schmitz I, Zha J, Korsmeyer SJ, Krammer PH, Peter ME . Differential modulation of apoptosis sensitivity in CD95 type I and type II cells. J Biol Chem 1999; 274:22532-8. 

  76. Nature M Irmler 388 190 1997 10.1038/40657 Irmler M, Thome M, Hahne M, et al. Inhibition of death receptor signals by cellular FLIP [see comments]. Nature 1997; 388:190-5. 

  77. J Biol Chem S Hu 272 17255 1997 10.1074/jbc.272.28.17255 Hu S, Vincenz C, Ni J, Gentz R, Dixit VM . I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1- and CD- 95-induced apoptosis. J Biol Chem 1997; 272:17255-7. 

  78. J Biol Chem SM Srinivasula 272 18542 1997 10.1074/jbc.272.30.18542 Srinivasula SM, Ahmad M, Ottilie S, et al. FLAME-1, a novel FADD-like anti-apoptotic molecule that regulates Fas/TNFR1-induced apoptosis. J Biol Chem 1997; 272:18542-5. 

  79. J Biol Chem YV Goltsev 272 19641 1997 10.1074/jbc.272.32.19641 Goltsev YV, Kovalenko AV, Arnold E, Varfolomeev EE, Brodianskii VM, Wallach D . CASH, a novel caspase homologue with death effector domains. J Biol Chem 1997; 272:19641-4. 

  80. Immunity L Van Parijs 11 763 1999 10.1016/S1074-7613(00)80150-8 Van Parijs L, Refaeli Y, Abbas AK, Baltimore D . Autoimmunity as a consequence of retrovirus-mediated expression of C-FLIP in lymphocytes. Immunity 1999; 11:763-70. 

  81. Eur J Immunol J Wang 30 155 2000 10.1002/1521-4141(200001)30:1<155::AID-IMMU155>3.0.CO;2-X Wang J, Lobito AA, Shen F, Hornung F, Winoto A, Lenardo MJ . Inhibition of Fas-mediated apoptosis by the B cell antigen receptor through c-FLIP. Eur J Immunol 2000; 30:155-63. 

  82. J Immunol EY Lin 151 1979 1993 10.4049/jimmunol.151.4.1979 Lin EY, Orlofsky A, Berger MS, Prystowsky MB . Characterization of A1, a novel hemopoietic-specific early-response gene with sequence similarity to bcl-2. J Immunol 1993; 151:1979-88. 

  83. J Biol Chem A Krikos 267 17971 1992 10.1016/S0021-9258(19)37138-8 Krikos A, Laherty CD, Dixit VM . Transcriptional activation of the tumor necrosis factor α-inducible zinc finger protein, A20, is mediated by κB elements. J Biol Chem 1992; 267:17971-6. 

  84. Cell S Takayama 80 279 1995 10.1016/0092-8674(95)90410-7 Takayama S, Sato T, Krajewski S, et al. Cloning and functional analysis of BAG-1: a novel Bcl-2-binding protein with anti-cell death activity. Cell 1995; 80:279-84. 

  85. Proc Natl Acad Sci USA L Pegoraro 81 7166 1984 10.1073/pnas.81.22.7166 Pegoraro L, Palumbo A, Erikson J, et al. A 14; 18 and an 8; 14 chromosome translocation in a cell line derived from an acute B-cell leukemia. Proc Natl Acad Sci USA 1984; 81:7166-70. 

  86. Nature D Hockenbery 348 334 1990 10.1038/348334a0 Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ . Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990; 348:334-6. 

  87. Cell M Rothe 83 1243 1995 10.1016/0092-8674(95)90149-3 Rothe M, Pan MG, Henzel WJ, Ayres TM, Goeddel DV . The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell 1995; 83:1243-52. 

  88. Cell L Wang 78 739 1994 10.1016/S0092-8674(94)90422-7 Wang L, Miura M, Bergeron L, Zhu H, Yuan J . Ich-1, an Ice/ced-3-related gene, encodes both positive and negative regulators of programmed cell death. Cell 1994; 78:739-50. 

  89. Science MX Wu 281 998 1998 10.1126/science.281.5379.998 Wu MX, Ao Z, Prasad KV, Wu R, Schlossman SF . IEX-1L, an apoptosis inhibitor involved in NF-$\kappa$B-mediated cell survival. Science 1998; 281:998-1001. 

  90. Nat Med G Ambrosini 3 917 1997 10.1038/nm0897-917 Ambrosini G, Adida C, Altieri DC . A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 1997; 3:917-21. 

  91. Science P Liang 257 967 1992 10.1126/science.1354393 Liang P, Pardee AB . Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction [see comments]. Science 1992; 257:967-71. 

  92. J Immunol J Mizuguchi 139 1054 1987 10.4049/jimmunol.139.4.1054 Mizuguchi J, Ji YY, Nakabayaschi H, et al. Protein kinase C activation blocks anti-IgM-mediated signaling BAL17 B lymphoma cells. J Immunol 1987; 139:1054-9. 

  93. Cell M Tewari 81 801 1995 10.1016/0092-8674(95)90541-3 Tewari M, Quan LT, O'Rourke K, et al. Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly (ADP-ribose) polymerase. Cell 1995; 81:801-9. 

  94. Nature DW Nicholson 376 37 1995 10.1038/376037a0 Nicholson DW, Ali A, Thornberry NA, et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis [see comments]. Nature 1995; 376:37-43. 

  95. Genomics G Lennon 33 151 1996 10.1006/geno.1996.0177 Lennon G, Auffray C, Polymeropoulos M, Soares MB . The I.M.A.G.E. Consortium: an integrated molecular analysis of genomes and their expression. Genomics 1996; 33:151-2. 

  96. Zhong X, Schneider TJ, Donohoe TJ, Rothstein TL . A novel isoform of Fas Apoptosis Inhibitory Molecule (FAIM)--cloning, genomic organization, alternative splicing and restricted expression. Submitted 2000; 

  97. Leukemia SC aimondi 3 42 1989 aimondi SC, Dube ID, Valentine MB, et al. Clinicopathologic manifestations and breakpoints of the t(3;5) in patients with acute nonlymphocytic leukemia. Leukemia 1989; 3:42-7. 

  98. Leukemia J Dierlamm 11 747 1997 10.1038/sj.leu.2400635 Dierlamm J, Rosenberg C, Stul M, et al. Characteristic pattern of chromosomal gains and losses in marginal zone B cell lymphoma detected by comparative genomic hybridization. Leukemia 1997; 11:747-58. 

  99. Cancer Res I Petersen 57 2331 1997 Petersen I, Bujard M, Petersen S, et al. Patterns of chromosomal imbalances in adenocarcinoma and squamous cell carcinoma of the lung. Cancer Res 1997; 57:2331-5. 

  100. J Exp Med M Djerbi 190 1025 1999 10.1084/jem.190.7.1025 Djerbi M, Screpanti V, Catrina AI, Bogen B, Biberfeld P, Grandien A . The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors [see comments]. J Exp Med 1999; 190:1025-32. 

  101. J Exp Med JP Medema 190 1033 1999 10.1084/jem.190.7.1033 Medema JP, de Jong J, van Hall T, Melief CJ, Offringa R . Immune escape of tumors in vivo by expression of cellular FLICE- inhibitory protein [see comments]. J Exp Med 1999; 190:1033-8. 

  102. Bioessays L Balvay 15 165 1993 10.1002/bies.950150304 Balvay L, Libri D, Fiszman MY . Pre-mRNA secondary structure and the regulation of splicing. Bioessays 1993; 15:165-9. 

  103. Trends Genet T Cavalier-Smith 7 145 1991 10.1016/0168-9525(91)90102-V Cavalier-Smith T . Intron phylogeny: a new hypothesis. Trends Genet 1991; 7:145-8. 

  104. Curr Opin Genet Dev JD Palmer 1 470 1991 10.1016/S0959-437X(05)80194-7 Palmer JD, Logsdon JM, Jr . The recent origins of introns. Curr Opin Genet Dev 1991; 1:470-7. 

  105. Cell P Lomedico 18 545 1979 10.1016/0092-8674(79)90071-0 Lomedico P, Rosenthal N, Efstratidadis A, Gilbert W, Kolodner R, Tizard R . The structure and evolution of the two nonallelic rat preproinsulin genes. Cell 1979; 18:545-58. 

  106. J Lipid Res WH Li 29 245 1988 10.1016/S0022-2275(20)38532-1 Li WH, Tanimura M, Luo CC, Datta S, Chan L . The apolipoprotein multigene family: biosynthesis, structure, structure-function relationships, and evolution. J Lipid Res 1988; 29:245-71. 

  107. Genetics JA Frugoli 149 355 1998 10.1093/genetics/149.1.355 Frugoli JA, McPeek MA, Thomas TL, McClung CR . Intron loss and gain during evolution of the catalase gene family in angiosperms. Genetics 1998; 149:355-65. 

  108. Eur J Immunol P Lane 22 2573 1992 10.1002/eji.1830221016 Lane P, Traunecker A, Hubele S, Inui S, Lanzavecchia A, Gray D . Activated human T cells expre ss a ligand for the human B cell- associated antigen CD40 which participates in T cell- dependent activation of B lymphocytes. Eur J Immunol 1992; 22:2573-8. 

  109. Proc Natl Acad Sci USA RJ Noelle 89 6550 1992 10.1073/pnas.89.14.6550 Noelle RJ, Roy M, Shepherd DM, Stamenkovic I, Ledbetter JA, Aruffo A . A 39- kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells. Proc Natl Acad Sci USA 1992; 89:6550-4. 

  110. Nature RJ Armitage 357 80 1992 10.1038/357080a0 Armitage RJ, Fanslow WC, Strockbine L, et al. Molecular and biological characterization of a murine ligand for CD40. Nature 1992; 357:80-2. 

  111. Nature ST Ju 373 444 1995 10.1038/373444a0 Ju ST, Panka DJ, Cui H, et al. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation [see comments]. Nature 1995; 373:444-8. 

  112. Nature T Brunner 373 441 1995 10.1038/373441a0 Brunner T, Mogil RJ, LaFace D, et al. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas [see comments]. Nature 1995; 373:441-4. 

  113. Nature J Dhein 373 438 1995 10.1038/373438a0 Dhein J, Walczak H, Baumler C, Debatin KM, Krammer PH . Autocrine T-cell suicide mediated by APO-1/(Fas/CD95) [see comments]. Nature 1995; 373:438-41. 

  114. J Exp Med MR Alderson 181 71 1995 10.1084/jem.181.1.71 Alderson MR, Tough TW, Davis-Smith T, et al. Fas ligand mediates activation-induced cell death in human T lymphocytes. J Exp Med 1995; 181:71-7. 

  115. Eur J Immunol M Ozdemirli 26 415 1996 10.1002/eji.1830260222 Ozdemirli M, El-Khatib M, Foote LC, et al. Fas (CD95)/Fas ligand interactions regulate antigen-specific, major histocompatibility complex-restricted T/B cell proliferative responses. Eur J Immunol 1996; 26:415-9. 

  116. 10.1002/1521-4141(200003)30:3<931::AID-IMMU931>3.0.CO;2-H Wang JKM, Ju ST, Marshak-Rothstein A . Protection of T cells from activation-induced cell death by Fas+ B cells. Eur J Immunol 2000; in press. 

  117. Nature MJ Shlomchik 328 805 1987 10.1038/328805a0 Shlomchik MJ, Marshak-Rothstein A, Wolfowicz CB, Rothstein TL, Weigert MG . The role of clonal selection and somatic mutation in autoimmunity. Nature 1987; 328:805-11. 

  118. Clin Immunol Immunopathol CB Wolfowicz 46 382 1988 10.1016/0090-1229(88)90057-8 Wolfowicz CB, Sakorafas P, Rothstein TL, Marshak-Rothstein A . Oligoclonality of rheumatoid factors arising spontaneously in lor/ lpr mice. Clin Immunol Immunopathol 1988; 46:382-95. 

  119. J Exp Med M Shlomchik 171 265 1990 10.1084/jem.171.1.265 Shlomchik M, Mascelli M, Shan H, et al. Anti-DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation. J Exp Med 1990; 171:265-92. 

  120. Nature JC Rathmell 376 181 1995 10.1038/376181a0 Rathmell JC, Cooke MP, Ho WY, et al. CD95 (Fas)-dependent elimination of self-reactive B cells upon interaction with CD4+ T cells. Nature 1995; 376:181-4. 

  121. J Exp Med H Wang 190 639 1999 10.1084/jem.190.5.639 Wang H, Shlomchik MJ . Autoantigen-specific B cell activation in Fas-deficient rheumatoid factor immunoglobulin transgenic mice. J Exp Med 1999; 190:639-49. 

  122. J Exp Med MP Cooke 179 425 1994 10.1084/jem.179.2.425 Cooke MP, Heath AW, Shokat KM, et al. Immunoglobulin signal transduction guides the specificity of B cell-T cell interactions and is blocked in tolerant self-reactive B cells. J Exp Med 1994; 179:425-38. 

  123. Proc Natl Acad Sci USA JM Eris 91 4392 1994 10.1073/pnas.91.10.4392 Eris JM, Basten A, Brink R, Doherty K, Kehry MR, Hodgkin PD . Anergic self-reactive B cells present self antigen and respond normally to CD40-dependent T-cell signals but are defective in antigen-receptor-mediated functions. Proc Natl Acad Sci USA 1994; 91:4392-6. 

  124. J Exp Med WY Ho 179 1539 1994 10.1084/jem.179.5.1539 Ho WY, Cooke MP, Goodnow CC, Davis MM . Resting and anergic B cells are defective in CD28-dependent costimulation of naive CD4+ T cells. J Exp Med 1994; 179:1539-49. 

  125. J Immunol HJ Burstein 147 2950 1991 10.4049/jimmunol.147.9.2950 Burstein HJ, Tepper RI, Leder P, Abbas AK . Humoral immune functions in IL-4 transgenic mice. J Immunol 1991; 147:2950-6. 

  126. J Exp Med KJ Erb 185 329 1997 10.1084/jem.185.2.329 Erb KJ, Ruger B, von Brevern M, Ryffel B, Schimpl A, Rivett K . Constitutive expression of interleukin (IL)-4 {\sl in vivo} causes autoimmune- type disorders in mice. J Exp Med 1997; 185:329-39. 

  127. J Exp Med JC Rathmell 188 651 1998 10.1084/jem.188.4.651 Rathmell JC, Fournier S, Weintraub BC, Allison JP, Goodnow CC . Repression of B7.2 on self-reactive B cells is essential to prevent proliferation and allow Fas-mediated deletion by CD4(+) T cells. J Exp Med 1998; 188:651-9. 

  128. Arch Surg JT DiPiro 130 1159 1995 10.1001/archsurg.1995.01430110017004 DiPiro JT, Howdieshell TR, Goddard JK, Callaway DB, Hamilton RG, Mansberger AR, Jr . Association of interleukin-4 plasma levels with traumatic injury and clinical course. Arch Surg 1995; 130:1159-62; discussion 1162-3. 

  129. Int Immunol C Klas 5 625 1993 10.1093/intimm/5.6.625 Klas C, Debatin KM, Jonker RR, Krammer PH . Activation interferes with the APO-1 pathway in mature human T cells. Int Immunol 1993; 5:625-30. 

  130. Immunity Y Refaeli 8 615 1998 10.1016/S1074-7613(00)80566-X Refaeli Y, Van Parijs L, London CA, Tschopp J, Abbas AK . Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis. Immunity 1998; 8:615-23. 

  131. J Immunol HE Broome 155 2311 1995 10.4049/jimmunol.155.5.2311 Broome HE, Dargan CM, Krajewski S, Reed JC . Expression of Bcl-2, Bcl-x, and Bax after T cell activation and IL-2 withdrawal. J Immunol 1995; 155:2311-7. 

  132. Eur J Immunol ME Peter 27 1207 1997 10.1002/eji.1830270523 Peter ME, Kischkel FC, Scheuerpflug CG, Medema JP, Debatin KM, Krammer PH . Resistance of cultured peripheral T cells towards activation-induced cell death involves a lack of recruitment of FLICE (MACH/caspase 8) to the CD95 death-inducing signaling complex. Eur J Immunol 1997; 27:1207-12. 

  133. J Biol Chem C Scaffidi 274 1541 1999 10.1074/jbc.274.3.1541 Scaffidi C, Schmitz I, Krammer PH, Peter ME . The role of c-FLIP in modulation of CD95-induced apoptosis. J Biol Chem 1999; 274:1541-8. 

  134. Eur J Immunol T Miethke 26 1459 1996 10.1002/eji.1830260709 Miethke T, Vabulas R, Bittlingmaier R, Heeg K, Wagner H . Mechanisms of peripheral T cell deletion: anergized T cells are Fas resistant but undergo proliferation-associated apoptosis. Eur J Immunol 1996; 26:1459-67. 

  135. J Immunol VA Boussiotis 159 3156 1997 10.4049/jimmunol.159.7.3156 Boussiotis VA, Lee BJ, Freeman GJ, Gribben JG, Nadler LM . Induction of T cell clonal anergy results in resistance, whereas CD28- mediated costimulation primes for susceptibility to Fas- and Bax- mediated programmed cell death. J Immunol 1997; 159:3156-67. 

  136. J Exp Med X Zhang 185 1837 1997 10.1084/jem.185.10.1837 Zhang X, Brunner T, Carter L, et al. Unequal death in T helper cell (Th)1 and Th2 effectors: Th1, but not Th2, effectors undergo rapid Fas/FasL-mediated apoptosis. J Exp Med 1997; 185:1837-49. 

  137. Proc Natl Acad Sci USA AS Varadhachary 94 5778 1997 10.1073/pnas.94.11.5778 Varadhachary AS, Perdow SN, Hu C, Ramanarayanan M, Salgame P . Differential ability of T cell subsets to undergo activation-induced cell death. Proc Natl Acad Sci USA 1997; 94:5778-83. 

  138. J Immunol MM Di Somma 162 3851 1999 10.4049/jimmunol.162.7.3851 Di Somma MM, Somma F, Montani MS, Mangiacasale R, Cundari E, Piccolella E . TCR engagement regulates differential responsiveness of human memory T cells to Fas (CD95)-mediated apoptosis. J Immunol 1999; 162:3851-8. 

  139. J Immunol M Inaba 163 1315 1999 10.4049/jimmunol.163.3.1315 Inaba M, Kurasawa K, Mamura M, Kumano K, Saito Y, Iwamoto I . Primed T cells are more resistant to Fas-mediated activation-induced cell death than naive T cells. J Immunol 1999; 163:1315-20. 

  140. Leukemia P Panayiotidis 9 1227 1995 Panayiotidis P, Ganeshaguru K, Foroni L, Hoffbrand AV . Expression and function of the FAS antigen in B chronic lymphocytic leukemia and hairy cell leukemia. Leukemia 1995; 9:1227-32. 

  141. Leukemia L Xerri 11 1868 1997 10.1038/sj.leu.2400815 Xerri L, Devilard E, Hassoun J, Haddad P, Birg F . Malignant and reactive cells from human lymphomas frequently express Fas ligand but display a different sensitivity to Fas-mediated apoptosis. Leukemia 1997; 11:1868-77. 

  142. Blood J Plumas 91 2875 1998 10.1182/blood.V91.8.2875.2875_2875_2885 Plumas J, Jacob MC, Chaperot L, Molens JP, Sotto JJ, Bensa JC . Tumor B cells from non-Hodgkin's lymphoma are resistant to CD95 (Fas/Apo-1)-mediated apoptosis. Blood 1998; 91:2875-85. 

  143. Br J Haematol L Xerri 106 652 1999 10.1046/j.1365-2141.1999.01586.x Xerri L, Devilard E, Bouabdallah R, Stoppa AM, Hassoun J, Birg F . FADD expression and caspase activation in B-cell lymphomas resistant to Fas-mediated apoptosis. Br J Haematol 1999; 106:652-61. 

  144. Cancer Res LB Owen-Schaub 54 1580 1994 Owen-Schaub LB, Radinsky R, Kruzel E, Berry K, Yonehara S . Anti-Fas on nonhematopoietic tumors: levels of Fas/APO-1 and bcl-2 are not predictive of biological responsiveness. Cancer Res 1994; 54:1580-6. 

  145. Oncogene G Natoli 11 1157 1995 Natoli G, Ianni A, Costanzo A, et al. Resistance to Fas-mediated apoptosis in human hepatoma cells. Oncogene 1995; 11:1157-64. 

  146. Cancer Res MM Keane 56 4791 1996 Keane MM, Ettenberg SA, Lowrey GA, Russell EK, Lipkowitz S . Fas expression and function in normal and malignant breast cell lines. Cancer Res 1996; 56:4791-8. 

  147. Cancer Res H Ungefroren 58 1741 1998 Ungefroren H, Voss M, Jansen M, et al. Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis. Cancer Res 1998; 58:1741-9. 

  148. Prostate TE Hedlund 36 92 1998 10.1002/(SICI)1097-0045(19980701)36:2<92::AID-PROS4>3.0.CO;2-G Hedlund TE, Duke RC, Schleicher MS, Miller GJ . Fas-mediated apoptosis in seven human prostate cancer cell lines: correlation with tumor stage. Prostate 1998; 36:92-101. 

  149. Gynecol Oncol RL Baldwin 74 265 1999 10.1006/gyno.1999.5448 Baldwin RL, Tran H, Karlan BY . Primary ovarian cancer cultures are resistant to Fas-mediated apoptosis. Gynecol Oncol 1999; 74:265-71. 

  150. J Exp Med SL Peng 184 1149 1996 10.1084/jem.184.3.1149 Peng SL, Robert ME, Hayday AC, Craft J . A tumor-suppressor function for Fas (CD95) revealed in T cell-deficient mice. J Exp Med 1996; 184:1149-54. 

  151. Immunity D Traver 9 47 1998 10.1016/S1074-7613(00)80587-7 Traver D, Akashi K, Weissman IL, Lagasse E . Mice defective in two apoptosis pathways in the myeloid lineage develop acute myeloblastic leukemia. Immunity 1998; 9:47-57. 

  152. J Exp Med WF Davidson 187 1825 1998 10.1084/jem.187.11.1825 Davidson WF, Giese T, Fredrickson TN . Spontaneous development of plasmacytoid tumors in mice with defective Fas-Fas ligand interactions. J Exp Med 1998; 187:1825-38. 

  153. J Exp Med LB Owen-Schaub 188 1717 1998 10.1084/jem.188.9.1717 Owen-Schaub LB, van Golen KL, Hill LL, Price JE . Fas and Fas ligand interactions suppress melanoma lung metastasis. J Exp Med 1998; 188:1717-23. 

  154. J Immunol RR Furman 164 2200 2000 10.4049/jimmunol.164.4.2200 Furman RR, Asgary Z, Mascarenhas JO, Liou HC, Schattner EJ . Modulation of NF-κB activity and apoptosis in chronic lymphocytic leukemia B cells. J Immunol 2000; 164:2200-6. 

  155. Int J Cancer S Ugurel 82 727 1999 10.1002/(SICI)1097-0215(19990827)82:5<727::AID-IJC17>3.0.CO;2-E Ugurel S, Seiter S, Rappl G, Stark A, Tilgen W, Reinhold U . Heterogenous susceptibility to CD95-induced apoptosis in melanoma cells correlates with bcl-2 and bcl-x expression and is sensitive to modulation by interferon- γ. Int J Cancer 1999; 82:727-36. 

관련 콘텐츠

원문 보기

원문 URL 링크

*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.

오픈액세스(OA) 유형

BRONZE

출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로